Taloyan, Marina
Wågström, Victor
Steiner, Kristin Hjörleifdottir
Yarbakht, Danial
Östenson, Claes-Göran
Salminen, Helena
Funding for this research was provided by:
Karolinska Institute
Article History
Received: 5 July 2022
Accepted: 15 March 2023
First Online: 22 March 2023
Declarations
:
: An ethical permit was granted by the Regional Ethical Review Board in Stockholm, review number 2013/2303–31/3. Data were collected after written informed consent was obtained from participants. Data were coded to maintain participant privacy. Both the study information sheet and the consent forms were translated from Swedish into the three most-spoken languages among the participants: Turkish, Farsi, and Arabic. Participants with abnormal blood test results were scheduled at the PHCC for further diagnosis and treatment if indicated. Those subsequently found to have diabetes were booked at the PHCC for regular follow-up. All methods were performed to the relevant guidelines and regulations (e.g. Declaration of Helsinki).
: Not applicable.
: The authors declare no competing interests.